The efficacy of glucosamine and chondroitin sulfate in osteoarthritis management: Review;Glukozamin ve kondroitin sülfatin osteoartrit tedavisindeki etkinliǧi

Turkiye Klinikleri Journal of Medical Sciences

Volumn 29, Issue 6, 2009, Pages 1687-1694

  Alptekin, Derya Özmen ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Chondroitin; Glucosamine; Osteoarthritis

Indexed keywords

CHONDROITIN SULFATE; GLUCOSAMINE;

ARTICULAR CARTILAGE; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; OSTEOARTHRITIS; REVIEW; SYMPTOM;

EID: 76749118154     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. nd ed. London: Mosby; 1998. p.8.6.1-16.
2. Creamer P, Hochberg MC. Osteoarthritis. Lancet 1997;350(9076):503-8.
3. st ed. İstanbul: Nobel Medicine Bookstores; 2007. p.1-7.
4. Sarzi-Puttini P, Cimmino MA, Scarpa R, Caporali R, Parazzini F, Zaninelli A, et al. Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum 2005;35(1 Suppl 1):1-10.
5. st ed. Ankara: Günes Bookstore; 2000. p. 13-8.
6. st ed. İstanbul: Nobel Medicine Bookstores; 2007. p.51-71.
7. st ed. Ankara: Güneş Bookstore; 2000. p.109-21.
8. McHughes M, Lipman AG. Managing osteoarthritis pain when your patient fails simple analgesics and NSAIDs and is not a candidate for surgery. Curr Rheumatol Rep 2006;8(1):22-9.
9. McColl GJ. Pharmacological therapies for the treatment of osteoarthritis. Med J Aust 2001;175(Suppl):S108-11.
10. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommitee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43(9):1905-15.
11. Pelletier JP, Martel-Pelletier J. DMOAD developments: present and future. Bull NYU Hosp Jt Dis 2007;65(3):242-8.
12. st ed. İstanbul: Nobel Medicine Bookstores; 2007. p.243-8.
13. Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999;25(2):379-95.
14. McAlindon TE. Nutraceuticals: do they work and when should we use them? Best practice and research. Clinical Rheumatology 2006;20(1):99-115.
15. Phoon S, Manolios N. Glucosamine. A nutraceutical in osteoarthritis. Aust Fam Physician 2002;31(6):539-41.
16. Tat SK, Pelletier JP, Vergés J, Lajeunesse D, Montell E, Fahmi H, et al. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study. Arthritis Res Ther 2007;9(6):R117.
17. Reginster JY, Bruyere O, Fraikin G, Henrotin Y. Current concepts in the therapeutic management of osteoarthritis with glucosamine. Bull Hosp Jt Dis 2005;63(1-2):31-6.
18. st ed. Ankara: MD Publishing; 2000. p.189-93.
19. Simánek V, Kren V, Ulrichová J, Gallo J. The efficacy of glucosamine and chondroitin sulfate in the treatment of osteoarthritis: are these saccharides drugs or nutraceuticals? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149(1):51-6.
20. Dodge GR, Jimenez SA. Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthritis Cartilage 2003;11(6):424-32.
21. Verbruggen G. Chondroprotective drugs in degenerative joint diseases. Rheumatology (Oxford) 2006;45(2):129-38.
22. Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet 2005;365(9463):965-73.
23. Blanco FJ, Guitian R, Vázquez-Martul E, de Tora FJ, Galdo F. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum 1998;41(2):284-9.
24. Tiraloche G, Girard C, Chouinard L, Sampalis J, Moquin L, Ionescu M, et al. Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Arthritis Rheum 2005;52(4):1118-28.
25. Michel BA, Stucki G, Frey D, De Vathaire F, Vignon E, Bruehlmann P, et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum. 2005;52(3)779-86.
26. Reginster JY, Bruyere O, Neuprez A. Current role of glucosamine in the treatment of osteoarthritis. Rheumatology (Oxford) 2007;46(5):731-5.
27. EpMoti LT, Haritha N, Mohit J, Praveen Y. Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipooxidation reactions and protein oxidation. Arthritis Research and Therapy 2007;9:R76.
28. Vlad SC, LaValley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum 2007;56(7):2267-77.
29. Krasnokutsky S, Samuels J, Abramson SB. Osteoarthritis in 2007. Bull NYU Hosp Jt Dis 2007;65(3):222-8.
30. Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 2003;163(13):1514-22.
31. Ameye LG, Chee WS. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 2006;8(4):R127.
32. Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage 2006;14(3):286-94.
33. Usha PR, Naidu MU. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in psteoarthritis. Clin Drug Investig 2004;24(6):353-63.
34. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354(8)795-808.
35. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283(11):1469-75.
36. Poolsup N, Suthisisang C, Channark P, Kittikulsuth W. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Ann Pharmacother 2005;39(6):1080-7.
37. Cohen M, Wolfe R, Mai T, Lewis D. A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol 2003;30(3):523-8.
38. Davenport G; Primary Care Rheumatology Society Steering Committee. Rheumatology and musculoskeletal medicine. Br J Gen Pract 2004;54(503):457-64.
39. Ruane R, Griffiths P. Glucosamine therapy compared to ibuprofen for joint pain. Br J Community Nurs 2002;7(3):148-52.
40. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001;357(9252):251-6.
41. Pavelká K, Gatterová J, Olejarová M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002;162(18):2113-23.
42. Anderson JW, Nicolosi RJ, Borzelleca JF. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol 2005;43(2):187-201.
43. Monauni T, Zenti MG, Cretti A, Daniels MC, Targher G, Caruso B, et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 2000;49(6):926-35.
44. Scroggie DA, Albright A, Harris MD. The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Arch Intern Med 2003;163(13):1587-90.
45. Muniyappa R, Karne RJ, Hall G, Crandon SK, Bronstein JA, Ver MR, et al. Oral glucosamine for 6 weeks at standart doses does not cause or worsen insulin resistance or endotelial dysfunction in lean or obese subjects. Diabetes 2006;55(11):3142-50.
46. Pham T, Cornea A, Blick KE, Jenkins A, Scofield RH. Oral glucosamine in doses used to treat osteoarthritis worsens insulin resistance. Am J Med Sci 2007;333(6):333-9.
47. Adams ME. Hype about glucosamine. Lancet 1999;354(9176):353-4.
48. Knudsen JF, Sokol GH. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. Pharmacotherapy 2008;28(4):540-8.